Precision oncology company Black Diamond Therapeutics raises $85m
Black Diamond Therapeutics, a precision oncology company based in Cambridge, has raised $85 million from a Series C financing round led by Boxer Capital of ... Read More
SHINE raises capital for medical isotope production facility from Oaktree
SHINE Medical Technologies has secured $50 million financing with funds managed by Oaktree Capital Management to support its upcoming medical isotope production facility and the ... Read More
Orchard Therapeutics raises $150m in Series C funding to advance gene therapies for rare diseases
Orchard Therapeutics, a leader in gene therapy specializing in rare diseases, has successfully secured $150 million through a Series C funding round. This substantial capital ... Read More